To further validate the pathological implications of HSP70 phosphorylation in cancer cells, we analyzed the basic phosphorylation of HSP70 in the absence of EGF signaling in normal and cancerous lung cells harboring mutations in EGFR or K-Ras, which is a well-studied activator of ERK28. This evidence concerns the gene KRAS and cancer.